ARTICLE | Financial News
Micromet planning follow-on
November 11, 2010 1:57 AM UTC
Micromet Inc. (NASDAQ:MITI) said late Wednesday that it is planning a follow-on underwritten by Piper Jaffray. Further details were not disclosed. Micromet's lead candidate, blinatumomab ( MT103), is ...